Azoy Alexander — SEC insider filings
SEC reporting owner CIK 1771961. 18 insider filings on record with FilingPulse; latest filed 2026-08-24.
Transaction summary — filings shown
Covers all 18 filings on record, filed 2020-09-15 to 2026-08-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 12 legs across 10 filings — 23,389 shares, $499,615 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 4,343 shares @ $22.25 ($96,614) in Arcus Biosciences, Inc., filed 2025-12-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Arcus Biosciences, Inc. (RCUS) | Chief Accounting Officer | 17 | — | 12 legs · 23,389 sh · $499,615 | 15 |
| Unity Biotechnology, Inc. (UBX) | See Remarks | 1 | — | — | 1 |
Insider filings — Azoy Alexander
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-24 | 4 | Arcus Biosciences, Inc. (RCUS) | Option exercise (M): 2,827 @ $15.44 · Sale (S): 2,827 @ $30 · Option exercise (M): 2,827 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 2,562 @ $25.77 | EDGAR |
| 2026-01-26 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 21,050 @ $0 · Grant/award (A): 14,050 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 2,376 @ $21.88 · Sale (S): 2,113 @ $22.16 · Sale (S): 4,343 @ $22.25 | EDGAR |
| 2025-12-01 | 4 | Arcus Biosciences, Inc. (RCUS) | Option exercise (M): 1,900 @ $13.33 · Sale (S): 1,900 @ $26 · Option exercise (M): 1,900 (derivative) @ $0 | EDGAR |
| 2025-09-30 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 2,831 @ $13 | EDGAR |
| 2025-09-05 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 1,579 @ $11.88 | EDGAR |
| 2025-01-27 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 17,100 @ $0 · Grant/award (A): 11,400 (derivative) @ $0 | EDGAR |
| 2024-12-20 | 4 | Arcus Biosciences, Inc. (RCUS) | Disposition to issuer (D): 3,007 @ $15.17 | EDGAR |
| 2024-12-17 | 4 | Arcus Biosciences, Inc. (RCUS) | Tax withholding (F): 2,969 @ $16.08 | EDGAR |
| 2024-12-04 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 201 @ $15.32 | EDGAR |
| 2024-08-15 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 1,357 @ $14.97 | EDGAR |
| 2024-01-25 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 8,850 @ $0 · Grant/award (A): 5,900 (derivative) @ $0 | EDGAR |
| 2023-12-22 | 4 | Arcus Biosciences, Inc. (RCUS) | Disposition to issuer (D): 68 @ $18.21 | EDGAR |
| 2023-12-20 | 4 | Arcus Biosciences, Inc. (RCUS) | Disposition to issuer (D): 647 @ $17.74 · Disposition to issuer (D): 661 @ $18.09 | EDGAR |
| 2023-12-05 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 282 @ $14.95 | EDGAR |
| 2023-07-05 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 1,018 @ $20.41 | EDGAR |
| 2020-09-15 | 4 | Unity Biotechnology, Inc. (UBX) | Grant/award (A): 135,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1771961 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs